Phathom Pharmaceuticals, Inc. — Form 8-K
Filed October 23, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 12/100
What the filing says
Phathom Pharmaceuticals filed an 8-K on October 23, 2026, under Item 8.01 (Other Events), but the actual substantive content of the event is not provided in the filing excerpt supplied. No counterparties, dollar amounts, dates, share counts, or specific business changes are disclosed in the available text.
Why this rating
Item 8.01 is boilerplate catch-all; no material facts disclosed. Cannot assess business impact without substance.
Extracted items
See more from October 23, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.